Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help bring them back.

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. There is a lot of skepticism around the prospect of reviving extinct animals like the ...

Imagine a world where the majestic woolly mammoth roams the Arctic tundra once again, thousands of years after its extinction. It might sound like the plot of a science fiction movie, but scientists ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

Inside, between rows of incubators and microscopes, Beth Shapiro and her team are attempting a feat straight out of science ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Colossal Biosciences, which is known for its plans to revive extinct animals, says that ...

Many remarkable animal species have gone extinct due to human activities, climate change, and habitat destruction. The Spix’s ...

Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.

Colossal Biosciences raises $200 million, valued at $10.2 billion. Animal Capital's $400,000 investment now worth $50 million ...

All around the world, scientists are working to recreate lost animal species such as the mammoth. Using modern genetic ...